NIH Highlighted Topic: Priority Research Questions in Fundamental Cellular and Molecular Neuroscience
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The National Institutes of Health (NIH) is seeking innovative research proposals through the SBIR Program focused on advancing fundamental cellular and molecular neuroscience. NIH is particularly interested in technologies, tools, and research platforms that improve understanding of the molecular architecture, dynamic interactions, signaling processes, and cellular organization of neurons and glia in vivo.
This highlighted topic aims to accelerate discoveries in foundational neuroscience by supporting development of advanced imaging systems, biosensors, computational models, molecular mapping technologies, and other enabling research tools that address critical knowledge gaps in nervous system function. Companies developing neurotechnology platforms, imaging systems, biosensors, AI-enabled neuroscience tools, molecular mapping technologies, computational biology solutions, or advanced in vivo research systems may be strong candidates for funding.
NIH is especially interested in projects focused on macromolecular cartography, molecular turnover and plasticity, developmental cellular dynamics, metabolic signaling, lipid dynamics, neural communication pathways, synaptic biology, neuroimmune interactions, and blood-brain barrier biology. Research integrating engineering, chemistry, biophysics, quantum sensing, computational modeling, and advanced optical imaging approaches is strongly encouraged.
Through the NIH SBIR Program, U.S. small businesses may apply for up to $323,090 in Phase I funding and up to $2,153,927 in Phase II funding to support research, development, validation, and commercialization activities. Applications are accepted on January 5th, April 5th, and September 5th annually, with funding typically beginning approximately 9 months after submission.
This highlighted topic is supported primarily by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), the National Eye Institute (NEI), and the Office of Research on Women’s Health (ORWH), all of which may give special consideration to high-impact applications advancing neurotechnology, brain imaging, molecular neuroscience, neural signaling research, and translational neuroscience tools.
How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for?
Funding may support the research, development, validation, and commercialization of technologies and research platforms focused on cellular and molecular neuroscience, neural imaging, and advanced neurobiology tools.
Eligible activities may include:
Development of advanced in vivo imaging systems for neural tissue analysis
Optical imaging technologies for subcellular and tissue-scale neuroscience applications
Quantum sensors and biosensors for neuronal activity detection and longitudinal monitoring
AI and machine learning platforms for neural data analysis and molecular mapping
Development of fluorescent, acoustic, bioluminescent, or metabolic imaging agents
Technologies supporting macromolecular cartography and protein interaction mapping in neurons and glia
Research tools studying synaptic plasticity, organelle dynamics, and cellular resilience
Spatiotemporal tools measuring molecular turnover, signaling, and protein stability
Computational models of neural development, cell signaling, and neuroimmune interactions
Technologies investigating blood-brain barrier formation, apoptosis, and neurodevelopmental dynamics
Metabolic and lipid signaling sensors for nervous system research
Research platforms focused on neurotransmission, neuromodulation, gliotransmission, and extracellular signaling
Sex-specific neuroscience research investigating molecular and cellular differences in neural systems
Translational neuroscience tools supporting drug discovery, neurological disease research, and brain health
Validation studies, prototype development, translational research, and regulatory preparation activities
Commercialization planning and scale-up activities for neuroscience technologies and imaging platforms
Funding may also support personnel, laboratory testing, software development, computational infrastructure, prototype fabrication, imaging system development, intellectual property protection, commercialization strategy development, and other research and development activities necessary to advance a commercially viable solution aligned with NIH priorities.
Are there any additional benefits I would receive?
Beyond the formal funding award, awardees gain several strategic advantages:
Government Validation and Credibility:
Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.Enhanced Visibility and Market Recognition:
Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities.Access to the Federal Innovation Ecosystem:
Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.Stronger Commercial and Exit Potential:
By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment.
What is the timeline to apply and when would I receive funding?
Applications are accepted each year on January 5th, April 5th, and September 5th. Funding is received approximately 9 months after submission.
Where does this funding come from?
Funding comes from the U.S. Department of Health and Human Services, with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.2% for SBIR, 0.45% for STTR) to support small business innovation.
Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that:
Are organized for profit with a U.S. place of business.
Have ≤ 500 employees including affiliates.
Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win?
Projects that demonstrate:
A clear unmet medical or public-health need,
Strong scientific rationale and feasibility,
High commercialization potential, supported by a realistic market and regulatory strategy, and
Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption.
Are there any restrictions I should know about?
Companies must complete multiple federal registrations (SAM.gov, Grants.gov, eRA Commons, SBA Company Registry) before applying.
Foreign entities are not eligible.
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.
